Gemini Therapeutics, Inc.

NasdaqGM:GMTX 주식 보고서

시가총액: US$58.5m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Gemini Therapeutics 관리

관리 기준 확인 1/4

주요 정보

Georges Gemayel

최고 경영자

US$717.4k

총 보상

CEO 급여 비율5.3%
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간1.2yrs
이사회 평균 재임 기간2.7yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Georges Gemayel 의 보수는 Gemini Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$59m

Mar 31 2022n/an/a

-US$68m

Dec 31 2021US$717kUS$38k

-US$72m

보상 대 시장: Georges's total compensation ($USD717.44K) is about average for companies of similar size in the US market ($USD749.99K).

보상과 수익: Insufficient data to compare Georges's compensation with company performance.


CEO

Georges Gemayel (62 yo)

less than a year

테뉴어

US$717,436

보상

Dr. Georges Gemayel, Ph D.,CFA, serves as Director of GlycoEra AG since July 2022. He has been Executive Chairperson of Gemini Therapeutics, Inc. since November 2021 and has been its Interim President and...


리더십 팀

이름위치테뉴어보상소유권
Georges Gemayel
Interim President & CEO and Executive Chairpersonless than a yearUS$717.44k데이터 없음
Brian Piekos
Chief Business Officer1.8yrsUS$4.17m0%
$ 0
Jason Meyenburg
Advisorno dataUS$10.36m0%
$ 0
Patrick Truesdell
VP of Finance & Controller1.2yrs데이터 없음데이터 없음

1.2yrs

평균 재임 기간

45yo

평균 연령

경험이 풍부한 관리: GMTX's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


이사회 구성원

이름위치테뉴어보상소유권
Georges Gemayel
Interim President & CEO and Executive Chairperson1.6yrsUS$717.44k데이터 없음
Carl Gordon
Independent Director6.7yrsUS$78.55k0.040%
$ 23.3k
David Lubner
Independent Director2.7yrsUS$749.99k0%
$ 0
Jason Rhodes
Independent Director6.7yrsUS$74.67k0.040%
$ 23.3k
John Atkinson
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Napoleone Ferrara
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Tuyen Ong
Independent Director2.3yrsUS$750.00k0%
$ 0
Aravind Asokan
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Dean Bok
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Ehrmann
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Shannon Boye
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Catherine Rickman
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

2.7yrs

평균 재임 기간

57.5yo

평균 연령

경험이 풍부한 이사회: GMTX's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.